BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1120228)

  • 1. Letter: New causes of malignant hyperpyrexia.
    Lack JA
    Br Med J; 1975 Jan; 1(5948):36-7. PubMed ID: 1120228
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: New causes of malignant hyperpyrexia.
    Ellis FR; Clarke IM; Mogill EM; Appleyard TN; Dinsdale RC
    Br Med J; 1975 Mar; 1(5957):575. PubMed ID: 1139164
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hyperpyrexia in the cat.
    de Jong RH; Heavner JE; Amory DW
    Anesthesiology; 1974 Dec; 41(6):608-9. PubMed ID: 4433061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant hyperthermia following nitrous oxide-halothane anesthesia].
    Stovner J; Sundt T; Mohr B; Lilleaasen P
    Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1512-6. PubMed ID: 1179364
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Malignant hyperthermia in the dog.
    Short CE; Paddleford RR
    Anesthesiology; 1973 Oct; 39(4):462-3. PubMed ID: 4758363
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations.
    Lewandowski KB
    Br J Anaesth; 1981 Sep; 53(9):981-4. PubMed ID: 7284224
    [No Abstract]   [Full Text] [Related]  

  • 7. Pale, soft exudative pork, porcine stress syndrome and malignant hyperpyrexia--an identity?
    Harrison GG
    J S Afr Vet Assoc; 1972 Mar; 43(1):57-63. PubMed ID: 4680363
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Malignant hyperthermia.
    Stephen CR
    South Med J; 1975 Jul; 68(7):801-2. PubMed ID: 1154068
    [No Abstract]   [Full Text] [Related]  

  • 9. [Morphology of the muscles and brain in case of malignant hyperthermia].
    Kozłowski PB
    Patol Pol; 1980; 31(1):147-52. PubMed ID: 7393646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant hyperthermia].
    Pöntinen PJ; Abele K; Autere T
    Duodecim; 1974; 90(1):55-8. PubMed ID: 4849136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malignant hyperthermia in Belgian landrace pigs].
    Oyaert W; Van Den Hende C; Muylle E
    Verh K Acad Geneeskd Belg; 1976; 38(5):209-34. PubMed ID: 1027298
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carpopedal spasm during anesthesia with halothane: malignant hyperthermia or tetany?].
    Kancir CB
    Ann Fr Anesth Reanim; 1986; 5(2):170-2. PubMed ID: 3729092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia.
    Baraka A; Rebeiz J; Moghrabi R
    Middle East J Anaesthesiol; 1974 Oct; 4(3):217-21. PubMed ID: 4480612
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: New causes of malignant hyperpyrexia.
    Br Med J; 1974 Nov; 4(5943):488. PubMed ID: 4434113
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Malignant hyperpyrexia.
    Moulds RF
    Lancet; 1975 Mar; 1(7908):681. PubMed ID: 47102
    [No Abstract]   [Full Text] [Related]  

  • 16. [Case of malignant hyperthermia].
    Pogorel'tsev AG; Kochnev AN; Dorofeev AI; Tishin PE; Favr VV
    Vestn Khir Im I I Grek; 1976 Nov; 117(11):111. PubMed ID: 1014244
    [No Abstract]   [Full Text] [Related]  

  • 17. A protocol for malignant hyperthermia.
    Fernsebner B
    AORN J; 1980 Apr; 31(5):814-8. PubMed ID: 6899763
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperpyrexia during anaesthesia.
    Harrison GG; Biebuyck JF; Terblanche J; Dent DM; Hickman R; Saunders SJ
    Br Med J; 1968 Sep; 3(5618):594-5. PubMed ID: 5667993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laboratory animal model for malignant hyperpyrexia.
    Durbin CG; Rosenberg H
    J Pharmacol Exp Ther; 1979 Jul; 210(1):70-4. PubMed ID: 36478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia and the clean machine.
    McGraw TT; Keon TP
    Can J Anaesth; 1989 Sep; 36(5):530-2. PubMed ID: 2791177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.